- Allurion Announces Pricing of $20 million Public Offering and Concurrent Private Placement
- Allurion Announces Launch of Offering of Common Stock and Warrants
- Allurion Announces Publication of New Data Demonstrating Lean Mass Gains in Patients Experiencing 14% Weight Loss
- Allurion Announces Three Scientific Presentations at the 40th Annual Meeting of the American Society for Metabolic and Bariatric Surgery
- Allurion Announces the Appointment of Ojas A. Buch as Chief Operating Officer
- Allurion Announces Expansion of AI Weight Loss Coach to Support Patients on GLP-1s
- Allurion to Participate in Two Upcoming Investor Conferences in June 2024
- Allurion Announces Three Scientific Presentations at the European Congress on Obesity, Including Study on Lean Mass Preservation for Sustainable, Healthy Weight Loss
- Allurion Reports First Quarter 2024 Financial Results and Provides Business Update
- Allurion Announces Three Scientific Presentations at IFSO-European Chapter 2024, Including First-Ever 3-Year Weight Maintenance Survey
More ▼
Key statistics
On Wednesday, Allurion Technologies Inc (ALUR:NYQ) closed at 1.26, 51.81% above the 52 week low of 0.83 set on Jun 28, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.25 |
---|---|
High | 1.35 |
Low | 1.11 |
Bid | 1.20 |
Offer | 1.28 |
Previous close | 1.26 |
Average volume | 8.38m |
---|---|
Shares outstanding | 62.31m |
Free float | 36.37m |
P/E (TTM) | -- |
Market cap | 78.50m USD |
EPS (TTM) | -1.37 USD |
Data delayed at least 15 minutes, as of Jul 03 2024 18:10 BST.
More ▼